Venture capital firm

BioStar Capital

Healthcare investment firm pairing finance professionals with clinicians to back medical technology companies

Visit Website Get introducedRequest an introduction Write a Review

TrustList summary

BioStar Capital is an investment firm that backs medical technology companies. Its team combines experienced investment professionals with clinicians who are recognised as thought leaders in medicine, and it works through partnerships with the companies it funds.

What BioStar Capital does

Medical technology investing: puts capital into companies developing new medical devices and related technology.
Clinical expertise: draws on physician advisers who understand how products are used in practice.
Portfolio partnerships: stays involved with the companies it backs over time.

Clients

The firm partners with medical technology businesses. Its news page shows portfolio companies raising funding rounds and presenting at healthcare investor conferences, and its founder has appeared in the business press and on a medtech podcast.

Key facts

Track record: more than 17 years working in medical technology
Team: investment professionals and clinicians
Focus: medical devices and healthcare innovation

Summary written by TrustList from the business's own published information, Oct 2026.

Categories & features

Rankings

BioStar Capital is ranked on 2 TrustList rankings: #15 on 1 and #25 on 1.

Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. BioStar Capital has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.

Venture capital firm · 2 rankings

#15of 130
Growth stage
It is one of 15 here listing healthtech.
Of the top 69 here, 18 also cover artificial intelligence and 16 also cover seed stage; 16 also work in New York City and 13 also work in San Francisco.
Behind Bain Capital Ventures, ahead of Andreessen Horowitz (a16z).
#25of 147
Healthtech investors
It is one of 13 here listing growth stage.
Of the top 64 here, 16 also cover partners and 14 also cover biotech; 7 also work in Boston and 7 also work in Chicago.
Behind Merieux Equity Partners, ahead of Andreessen Horowitz (a16z).